Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - NAFTA

NAFTA

Revenue in the Diabetes Care Devices market market in the North American Free Trade Agreement (in North American Free Trade Agreement (NAFTA)) region is projected to reach US$14.15bn in 2025.
This revenue is anticipated to exhibit an annual growth rate (CAGR 2025-2029) of 11.61%, leading to a market volume of US$21.96bn by 2029.
In a global context, the majority of this revenue will be generated the United States, which is expected to account for US$13,070.00m in 2025.
In the United States, the Diabetes Care Devices market is increasingly integrating advanced digital health technologies to enhance patient management and self-monitoring capabilities.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market within the Medical Devices sector is witnessing considerable growth in the NAFTA region, fueled by increasing diabetes prevalence, technological advancements, and heightened consumer awareness regarding disease management.

Customer preferences: Consumers are increasingly prioritizing personalized diabetes care solutions that cater to their unique lifestyles and preferences, resulting in a growing demand for smart insulin pens and continuous glucose monitors that offer real-time data. Additionally, the rise of telehealth services is transforming how individuals manage their diabetes, enabling more frequent interactions with healthcare providers. This shift reflects a broader trend towards integrated health management, where technology plays a crucial role in enhancing patient engagement and self-management strategies.

Trends in the market: In North America, the Diabetes Care Devices Market is experiencing a surge in demand for smart insulin pens and continuous glucose monitors, as consumers seek personalized solutions that align with their lifestyles. In Mexico, there is an increasing adoption of telehealth services, facilitating remote consultations and improving access to diabetes management resources. Meanwhile, in Canada, integrated health management platforms are emerging, enabling seamless communication between patients and healthcare providers. These trends underscore the significance of technology in enhancing patient engagement and self-management, ultimately shaping the future landscape of diabetes care.

Local special circumstances: In the United States, the Diabetes Care Devices Market is propelled by a strong emphasis on innovation and consumer-driven healthcare, where patients demand advanced monitoring solutions that integrate with their daily lives. The regulatory environment, characterized by rigorous FDA approvals, ensures high safety standards, fostering confidence in new technologies. In contrast, in Mexico, cultural factors such as community support and family involvement in health decisions enhance the adoption of diabetes management devices, while government initiatives promote affordability and accessibility. Canada’s universal healthcare system supports the integration of diabetes technologies, encouraging holistic patient management and collaboration among healthcare providers.

Underlying macroeconomic factors: The Diabetes Care Devices Market is influenced by several macroeconomic factors, including global economic conditions, national healthcare expenditure, and fiscal policies. In the U.S., a robust economy drives investment in innovative diabetes technologies, supported by government funding for research and development. Conversely, Mexico's market is shaped by economic challenges that necessitate affordable solutions, prompting government initiatives to enhance healthcare access. Canada benefits from stable economic growth and fiscal policies that promote public health funding, facilitating the adoption of advanced diabetes management devices. Collectively, these factors shape market dynamics and innovation in diabetes care across North America.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.